vaccines

06/17/2019

IVI partners with QuadMedicine to develop microneedle-based vaccines

Dr. Jerome Kim (left), General Director of IVI and Mr. Seung-Ki Baek, CEO of QuadMedicine   June 17, 2019 – SEOUL, South Korea. Today IVI exchanged a memorandum of understanding with QuadMedicine, a Korea-based biotech venture, to collaborate on the development of microneedle-based vaccines. With […]
07/01/2019

Seoul Women’s University Prof. Yeonhee Lee gives talk on ‘Culture Collection of Antimicrobial-Resistant Microbes’ at IVI Seminar

Prof. Yeonhee Lee gives talk on ‘Culture Collection of Antimicrobial Resistant Microbes’   July 1, 2019 – SEOUL, South Korea. Prof. Yeonhee Lee, PhD, a professor at Seoul Women’s University and President of the Microbiological Society of Korea, delivered a lecture entitled: “Culture Collection of Antimicrobial-Resistant Microbes” on […]
07/10/2019

Seminar: Towards Affordable Conjugate Vaccines: Efficient Chemistry, Affordable CRM197 Carrier Protein and Supporting New Entrants

Dr. Andrew Lees, Scientific Director of Fina BioSolutions LLC, giving a seminar at IVI   July 9, 2019, Seoul, South Korea -Dr. Andrew Lees, Scientific Director of Fina BioSolutions LLC, gave a seminar today at IVI headquarters about the road towards affordable conjugate vaccines. During […]
07/12/2019

IVI exchanged a memorandum of understanding with the Armed Forces Medical Research Institute (AFMRI)

    Dr. Jerome Kim (left), Director General of IVI and Dr. Quehn Park, Commander of AFMRI   July 12, 2019 – SEOUL, South Korea. Today IVI exchanged a memorandum of understanding with the Armed Forces Medical Research Institute (AFMRI), the Korean military’s institution dedicated […]